| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |